MedTrace Logo

Effect of Preoperative Beta Blocker Use Postoperative Renal Function in the Patients Undergoing Liver Transplantation

NCT03633812 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 477

Last updated 2018-08-22

No results posted yet for this study

Summary

This is prospective cohort study of patients classified by the premedication history of beta-blocker. The investigators aim to evaluate the hemodynamic effect of beta blocker through Swan-Ganz catheter monitoring and arterial pressure waveform analysis during surgery. The investigators also plan to observe the long-term effects of beta blocker on acute renal failure, allograft failure and mortality.

Conditions

Interventions

OTHER

Observational study, Beta blocker medication history

Observational study, Beta blocker medication history

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Jun Gol Song, PH.D. · Asan Medical Center

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-28
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03633812 on ClinicalTrials.gov